Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell C Benson

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Urologic Oncology|April 18, 2021
Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancerJamie S Pak, Christopher R Haas, Christopher B Anderson, et al.
The Journal of Urology|March 20, 2010
Active surveillance for renal cortical neoplasmsJuan Carlos Rosales, Georgios Haramis, Jorge Moreno, et al.
Urology|December 3, 2014
Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practicesTomy Y Perez, Matthew R Danzig, Rashed A Ghandour, et al.
Urology|February 8, 2006
Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or largerRobert E Mitchell, Scott M Gilbert, Alana M Murphy, et al.
The Journal of Urology|June 18, 2011
A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancerJames M McKiernan, LaMont J Barlow, Melissa A Laudano, et al.
Urology|November 10, 2007
Prostate volume and pathologic prostate cancer outcomes after radical prostatectomyPhillip M Pierorazio, Michael D Kinnaman, Matthew S Wosnitzer, et al.
Urology|June 9, 2009
Prospective comparison of flexible fiberoptic and digital cystoscopesZhamshid Okhunov, Gregory W Hruby, Gabriella Mirabile, et al.
Urologic Oncology|December 13, 2003
Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicityJohn S Lam, Mitchell C Benson, Michael A O'Donnell, et al.
The Prostate|February 3, 2012
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancerJing Shen, Gregory W Hruby, James M McKiernan, et al.
BJU International|September 10, 2008
How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?Melissa A Laudano, Sarah M Lambert, Puneet Masson, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Urologic Oncology|April 18, 2021
Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancerJamie S Pak, Christopher R Haas, Christopher B Anderson, et al.
The Journal of Urology|March 20, 2010
Active surveillance for renal cortical neoplasmsJuan Carlos Rosales, Georgios Haramis, Jorge Moreno, et al.
Urology|December 3, 2014
Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practicesTomy Y Perez, Matthew R Danzig, Rashed A Ghandour, et al.
Urology|February 8, 2006
Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or largerRobert E Mitchell, Scott M Gilbert, Alana M Murphy, et al.
The Journal of Urology|June 18, 2011
A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancerJames M McKiernan, LaMont J Barlow, Melissa A Laudano, et al.
Urology|November 10, 2007
Prostate volume and pathologic prostate cancer outcomes after radical prostatectomyPhillip M Pierorazio, Michael D Kinnaman, Matthew S Wosnitzer, et al.
Urology|June 9, 2009
Prospective comparison of flexible fiberoptic and digital cystoscopesZhamshid Okhunov, Gregory W Hruby, Gabriella Mirabile, et al.
Urologic Oncology|December 13, 2003
Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicityJohn S Lam, Mitchell C Benson, Michael A O'Donnell, et al.
The Prostate|February 3, 2012
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancerJing Shen, Gregory W Hruby, James M McKiernan, et al.
BJU International|September 10, 2008
How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?Melissa A Laudano, Sarah M Lambert, Puneet Masson, et al.
Pageof 14